Reviva Pharmaceuticals (RVPH) PT Lowered to $7 at Benchmark as Additional Capital Likely Required
Tweet Send to a Friend
(Updated - September 15, 2025 9:04 AM EDT)
Benchmark analyst Bruce Jackson lowered the price target on Reviva Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Benchmark analyst Bruce Jackson lowered the price target on Reviva Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
